XML 16 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENT OF EARNINGS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenue $ 19,072 $ 18,155
Cost 10,825 10,211 [1]
Gross profit 8,247 7,944 [1]
Expense and other (income):    
Selling, general and administrative 5,445 5,027 [1]
Research, development and engineering 1,405 1,484 [1]
Intellectual property and custom development income (317) (445)
Other (income) and expense 413 319 [1]
Interest expense 165 135
Total expense and other (income) 7,111 6,521 [1]
Income from continuing operations before income taxes 1,136 1,424
Provision for/(benefit from) income taxes (540) (329)
Income from continuing operations 1,675 1,753
Income/(loss) from discontinued operations, net of tax 4 (3)
Net income $ 1,679 $ 1,750
Assuming dilution:    
Continuing operations (in dollars per share) $ 1.81 $ 1.85
Discontinued operations (in dollars per share) 0.00 0.00
Total (in dollars per share) 1.81 1.85
Basic:    
Continuing operations (in dollars per share) 1.82 1.86
Discontinued operations (in dollars per share) 0.00 0.00
Total (in dollars per share) $ 1.82 $ 1.86
Weighted-average number of common shares outstanding:    
Assuming dilution (in shares) 925,409,434 947,836,207
Basic (in shares) 920,680,222 942,440,901
Cash dividend per common share $ 1.50 $ 1.40
Services    
Revenue $ 12,961 $ 12,342
Cost 8,835 8,401 [1]
Sales    
Revenue 5,700 5,404
Cost 1,722 1,530 [1]
Financing    
Revenue 410 409
Cost $ 269 $ 279
[1] Recast to reflect adoption of the FASB guidance on presentation of net periodic pension and nonpension postretirement benefit costs.